Nebraska Health System — Omaha, Nebraska

Nebraska Health System is a clinical research site located in Omaha, Nebraska, United States 68105-1018.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Nebraska Health System has participated in 29 clinical trials.

Therapeutic areas: Prostate Cancer, Sarcoma, Diarrhea.

Sponsors: Radiation Therapy Oncology Group, National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Health System?

Nebraska Health System has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Health System conducted?

Nebraska Health System has 29 clinical trials on record. Their work covers Prostate Cancer, Sarcoma, Diarrhea.

Is Nebraska Health System accredited by Crixeo Health?

Yes — Nebraska Health System holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Nebraska Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.